Jundishapur Journal of Microbiology

Published by: Kowsar

Molecular Characterization of Carbapenem-Resistant Klebsiella pneumoniae Species Isolated From a Tertiary Hospital, Ankara, Turkey

Nevreste Celikbilek 1 , * , Ozlem Unaldi 2 , Fisun Kirca 1 , Aysegul Gozalan 1 , Ziya C Acikgoz 1 , 3 and Riza Durmaz 2 , 3
Authors Information
1 Ataturk Training and Research Hospital, Department of Medical Microbiology, Bilkent, Ankara, Turkey
2 Public Health Institution of Turkey, National Molecular Microbiology Reference Laboratory, Sihhiye, Ankara, Turkey
3 Yildirım Beyazit University, Faculty of Medicine, Department of Medical Microbiology, Bilkent, Ankara, Turkey
Article information
  • Jundishapur Journal of Microbiology: October 2017, 10 (10); e14341
  • Published Online: August 27, 2017
  • Article Type: Research Article
  • Received: February 28, 2017
  • Revised: May 31, 2017
  • Accepted: June 25, 2017
  • DOI: 10.5812/jjm.14341

To Cite: Celikbilek N, Unaldi O, Kirca F, Gozalan A, Acikgoz Z C, et al. Molecular Characterization of Carbapenem-Resistant Klebsiella pneumoniae Species Isolated From a Tertiary Hospital, Ankara, Turkey, Jundishapur J Microbiol. 2017 ; 10(10):e14341. doi: 10.5812/jjm.14341.

Abstract
Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Cristina ML, Sartini M, Ottria G, Schinca E, Cenderello N, Crisalli MP, et al. Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital. J Prev Med Hyg. 2016; 57(3)-56[PubMed]
  • 2. Sanchez M, Herruzo R, Marban A, Araujo P, Asensio MJ, Leyva F, et al. Risk factors for outbreaks of multidrug-resistant Klebsiella pneumoniae in critical burn patients. J Burn Care Res. 2012; 33(3): 386-92[DOI][PubMed]
  • 3. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011; 53(1): 60-7[DOI][PubMed]
  • 4. Watkins RR, Bonomo RA. Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis. Expert Rev Anti Infect Ther. 2013; 11(6): 543-5[DOI][PubMed]
  • 5. Eser OK, Altun Uludag H, Ergin A, Boral B, Sener B, Hascelik G. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections]. Mikrobiyol Bul. 2014; 48(1): 59-69[PubMed]
  • 6. Jin Y, Song X, Liu Y, Wang Y, Zhang B, Fan H, et al. Characteristics of carbapenemase-producing Klebsiella pneumoniae as a cause of neonatal infection in Shandong, China. Exp Ther Med. 2017; 13(3): 1117-26[DOI][PubMed]
  • 7. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front Microbiol. 2016; 7: 895[DOI][PubMed]
  • 8. Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004; 48(1): 15-22[DOI][PubMed]
  • 9. Carrer A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother. 2010; 54(3): 1369-73[DOI][PubMed]
  • 10. Canton R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012; 18(5): 413-31[DOI][PubMed]
  • 11. Nordmann P, Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013; 68(3): 487-9[DOI][PubMed]
  • 12. Clinical and Laboratory Standarts Institude . Performance standarts for antimicrobial susceptibility testing, approved standards and twenty-seventh informational supplement (M100-S27) CLSI 2017;
  • 13. Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, et al. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother. 2010; 65(8): 1664-71[DOI][PubMed]
  • 14. Ranjbar R, Karami A, Farshad S, Giammanco GM, Mammina C. Typing methods used in the molecular epidemiology of microbial pathogens: a how-to guide. New Microbiol. 2014; 37(1): 1-15[PubMed]
  • 15. Sabat AJ, Budimir A, Nashev D, Sa-Leao R, van Dijl J, Laurent F, et al. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill. 2013; 18(4): 20380[PubMed]
  • 16. Tenover FC, Arbeit RD, Goering RV. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1997; 18(6): 426-39[DOI][PubMed]
  • 17. Mohamed ER, Aly SA, Halby HM, Ahmed SH, Zakaria AM, El-Asheer OM. Epidemiological typing of multidrug-resistant Klebsiella pneumoniae, which causes paediatric ventilator-associated pneumonia in Egypt. J Med Microbiol. 2017; 66(5): 628-34[DOI][PubMed]
  • 18. Ohadian Moghadam S, Pourmand MR, Douraghi M, Sabzi S, Ghaffari P. Utilization of PFGE as a Powerful Discriminative Tool for the Investigation of Genetic Diversity among MRSA Strains. Iran J Public Health. 2017; 46(3): 351-6[PubMed]
  • 19. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003; 41(10): 4623-9[DOI][PubMed]
  • 20. Garza-Ramos U, Morfin-Otero R, Sader HS, Jones RN, Hernandez E, Rodriguez-Noriega E, et al. Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother. 2008; 52(8): 2943-6[DOI][PubMed]
  • 21. Gomez-Gil MR, Pano-Pardo JR, Romero-Gomez MP, Gasior M, Lorenzo M, Quiles I, et al. Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother. 2010; 65(12): 2695-7[DOI][PubMed]
  • 22. Poirel L, Bonnin RA, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother. 2012; 56(1): 559-62[DOI][PubMed]
  • 23. Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, Ersoy Y, et al. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis. 2009; 62(5): 372-7[PubMed]
  • 24. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29(11): 996-1011[DOI][PubMed]
  • 25. European Center for Disease Control . European Antimicrobial Resistance Surveillance Network. 2014;
  • 26. Us E, Tekeli A, Arikan Akan O, Dolapci I, Sahin F, Karahan ZC. [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey]. Mikrobiyol Bul. 2010; 44(1): 1-10[PubMed]
  • 27. Gur D, Hascelik G, Aydin N, Telli M, Gultekin M, Ogulnc D, et al. Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007. J Chemother. 2009; 21(4): 383-9[DOI][PubMed]
  • 28. Kuzucu C, Yetkin F, Gorgec S, Ersoy Y. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems]. Mikrobiyol Bul. 2011; 45(1): 28-35[PubMed]
  • 29. Zarakolu P, Eser OK, Aladag E, Al-Zahrani IA, Day KM, Atmaca O, et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013. Diagn Microbiol Infect Dis. 2016; 85(4): 466-70[DOI][PubMed]
  • 30. Girlich D, Poirel L, Nordmann P. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol. 2012; 50(2): 477-9[DOI][PubMed]
  • 31. Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012; 50(12): 3877-80[DOI][PubMed]
  • 32. Aktas Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy. 2008; 54(2): 101-6[DOI][PubMed]
  • 33. Cakar A, Akyon Y, Gur D, Karatuna O, Ogunc D, Ozhak Baysan B, et al. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey]. Mikrobiyol Bul. 2016; 50(1): 21-33[PubMed]
  • 34. Labarca J, Poirel L, Ozdamar M, Turkoglu S, Hakko E, Nordmann P. KPC-producing Klebsiella pneumoniae, finally targeting Turkey. New Microbes New Infect. 2014; 2(2): 50-1[DOI][PubMed]
  • 35. Alp E, Percin D, Colakoglu S, Durmaz S, Kurkcu CA, Ekincioglu P, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hosp Infect. 2013; 84(2): 178-80[DOI][PubMed]
  • 36. Karabay O, Altindis M, Koroglu M, Karatuna O, Aydemir OA, Erdem AF. The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey. Ann Clin Microbiol Antimicrob. 2016; 15: 6[DOI][PubMed]
  • 37. Yanik K, Emir D, Eroglu C, Karadag A, Guney AK, Gunaydin M. [Investigation of the presence of New Delhi metallo-beta-lactamase-1 (NDM-1) by PCR in carbapenem-resistant gram-negative isolates]. Mikrobiyol Bul. 2013; 47(2): 382-4[PubMed]
  • 38. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013; 13(9): 785-96[DOI][PubMed]
  • 39. Lopez-Cerero L, Egea P, Gracia-Ahufinger I, Gonzalez-Padilla M, Rodriguez-Lopez F, Rodriguez-Bano J, et al. Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain. Int J Antimicrob Agents. 2014; 44(6): 538-40[DOI][PubMed]
  • 40. Iraz M, Ozad Duzgun A, Sandalli C, Doymaz MZ, Akkoyunlu Y, Saral A, et al. Distribution of beta-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey. Ann Lab Med. 2015; 35(6): 595-601[DOI][PubMed]
  • 41. Sahin K, Tekin A, Ozdas S, Akin D, Yapislar H, Dilek AR, et al. Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates. Ann Clin Microbiol Antimicrob. 2015; 14: 44[DOI][PubMed]
  • 42. Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Am J Infect Control. 2006; 34(4): 188-92[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments